BlueReg has an experienced team for Product Quality Review (PQR) writing including Chemistry Manufacturing and Controls, Quality and Regulatory Affairs consultants dedicated to supporting your company through PQR reviews for your medicinal products
From data gathering, through data analysis and PQR writing, we provide flexible solutions to meet your company’s requirements
Our services
PQR is a regulatory requirement (EU-GMP chap 8, US 21 CFR part211, and ICHQ7A) and an effective quality improvement tool to verify the consistency of the existing process and overall quality of the product, to be conducted annually. These PQRs are assessed thoroughly by inspectors during Health Authority inspections and should be carefully managed by trained and knowledgeable staff.
BlueReg can fully support to set up the PQR process in your company and/or manage your annual reviews. Our experienced team utilise the following approach which can be tailored to your specific needs:
Data Gathering
- Manufacturer PQR
- Local data (variations, deviations, contracts, complaints and recalls)
Data Analysis
- Compliance to Good Manufacturing Practice (GMP) requirements
- Critical review of batch data evaluation performed by the manufacturer
- Evaluation of the overall quality of the product
- Assessment of the consistency of the existing manufacturing process
- Highlight of any trends
- Review of the proposed Corrective Action Preventive Actions (CAPAs), highlighting action plans to be monitored or added
- Verification of the consistency between local data and information provided by the manufacturer
Writing the PQR for the « Exploitant »
- Writing in accordance with the client or BlueReg template
- Assessing manufacturing results and setting conclusions on process control
- Providing a global assessment on the local data and the evaluation undertaken by the manufacturer
Associated services
Regulatory affairs consulting in France
The BlueReg team have a highly successful track record of delivering all French market specific services, from the simple to the complex providing expert advice as well as hands-on operational support.
Associated services
Role of Responsible Pharmacists in France
Looking for support in marketing your product in France? PharmaBlue, a BlueReg company, is a partner “Exploitant” of pharmaceutical companies for the marketing in France of their medicinal products which have been granted a temporary use authorization (ATU) or a marketing authorisation (MA).
Associated services
Promotional Material Review in France
BlueReg peut vous accompagner pour du conseil ou de la gestion opérationnelle afin de garantir la conformité de toutes vos opérations avec les exigences qui s’appliquent en France
Associated services
Worldwide
BlueReg consultants can help navigate International regulations and provide support and advice for all your project requirements
Associated services
United Kingdom
Looking for help and support in entering the UK? Our UK based consultants can provide support and advice for all your project requirements in relation to the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Associated services
United States
Looking for help with regulatory activities in the United States? BlueReg can help to navigate the Food and Drug Administration (FDA) regulations and provide support and advice for all your project requirements.
Associated services
Drug Registration and Regulatory Roadmap
BlueReg can be your preferred partner to support the registration of your medicinal product in Europe, in the US or in other worldwide countries. Our team of experts can also facilitate and guide clients through the process of formulating the roadmap, provide critical review of one or more elements of the roadmap, or provide hands on operational support through authoring some or all the components.
Associated services
Exploitant Services
Looking for support in marketing your product in France? PharmaBlue, a BlueReg company, is a partner “Exploitant” of pharmaceutical companies for the marketing in France of their medicinal products which have been granted a temporary use authorization (ATU) or a marketing authorisation (MA).
Associated services
Product Quality Review
BlueReg has an experienced team for Product Quality Review (PQR) writing including CMC, Quality and Regulatory Affairs consultants dedicated to supporting your company through PQR reviews for your medicinal products.
Associated services
Market Access France
BlueReg has a team of Market Access experts dedicated to supporting your company through the full pricing and reimbursement process (medicinal products and medical devices) in France.
Associated services
Brexit
BlueReg assists companies to plan and submit any necessary changes to existing marketing authorizations before the end of the Brexit transition period in order to comply with EU law. Please contact us or follow our BlueReg Linkedin page to be kept up to date with the Medicines and Healthcare products Regulatory Agency (MHRA) Brexit guidance as they are issued.
Associated services
Pharmacovigilance
BlueReg will help you make pharmacovigilance a more streamlined process through ongoing support and tailored feedback. We offer expert advice and bespoke consultancy to assist you with a complete range of pharmacovigilance services.
Associated services
Audits
BlueReg can assist with all your audit requirements and can provide a complete audit preparation package which we can tailor to your needs.
Associated services
Regulatory Affairs Consulting EU
Our team composed of global experts from the pharmaceutical industry provides the necessary support to help you succeed in all regulatory aspects of life sciences in Europe from development, registration through to commercialization.
Associated services
Early & Expanded Access Programs in France
Looking to reach market earlier ? You can rely on the experience and expertise of our consultants at BlueReg for providing advice and efficient implementation of your Early Access Programs projects in France .
Associated services
Pricing and reimbursement (Drugs and Medical devices)
BlueReg consultants can provide pricing and reimbursement insight and support you prior to the launch of your products in France. BlueReg has a team of Market Access experts dedicated to supporting your company through the full pricing and reimbursement process (medicinal products and medical devices).
Associated News
Nitrosamine impurities – are you ready to fulfil your legal obligations as a MAH by March 26th, 2020?
During the summer 2018, authorities become aware of the presence of some nitrosamines in API...
Learn more
During the summer 2018, authorities become aware of the presence of some nitrosamines in API...